ASN: Finerenone May Slow Progression in CKD With T2DM

MONDAY, Oct. 26, 2020 -- Finerenone results in a lower risk for chronic kidney disease (CKD) progression in patients with CKD and type 2 diabetes, according to a study published online Oct. 23 in the New England Journal of Medicine to coincide with...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news